Neuro-ophthalmology Update for Clinicians: 2025 brings the latest scientific advances in eye movement and vision research to the “clinic”, where ophthalmologists and neurologists diagnose and treat patients with neuro-ophthalmological disorders. Emphasis is on 1) the application and integration of the newer laboratory diagnostic techniques (e.g., video oculography, ocular coherence tomography (OCT), machine learning) into the traditional, bedside examination of patients with decreased or double vision, and 2) the remarkable advances, including gene therapy and neuroprotective agents, in treatment of the disabling disorders that affect eye movements and vision. These include demyelinating diseases such as optic neuritis and multiple sclerosis, degenerative diseases such as Parkinson’s disease, the autoimmune and genetic optic nerve and cerebellar syndromes, mitochondrial disorders, myasthenia gravis, and migraine. A particular relevance, this year, will be given to the new perspectives on management of optic neuritis spectrum disorders in MS and other immune mediated brain diseases. Participants will come away with new bedside diagnostic skills as well as the latest algorithms to successfully manage and treat their neuroophthalmology patients.
Per informazioni consultare la pagina dell’evento e contattare la Segreteria Organizzativa, Siena Congress
Roma, 13-14 giugno 2025